Scan this code to launch
www.basaglar.com
This Instructions for Use have been approved by the U.S. Food and Drug Administration.
BASAGLAR
®
and BASAGLAR
®
KwikPen
®
are trademarks of Eli Lilly and Company.
Instructions for Use revised: September 2018
Marketed by:
Lilly USA, LLC
Indianapolis, IN 46285, USA
and
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT 06877, USA
Copyright © 2015, 2018, Eli Lilly and Company. All rights reserved.
BI (logo) Lilly (red script)
BASKP-0005-IFU-20180905
BASAGLAR KwikPen meets the current dose accuracy and functional requirements of ISO 11608-1:2014.
To Previous Page
Loading...